Last Call: Register Now for Hill Event
It’s not too late to make plans to join us and The Hill in-person or virtually on June 27, for “Medicare & Drug Pricing: Time to Think Differently.” Get a deep dive into the Inflation Reduction Act’s impact on drug pricing, access, and Medicare equity from the following experts and policymakers:
Rep. Scott Peters (D-CA): Member, Energy & Commerce Committee
Rep. Mariannette Miller-Meeks, MD (R-IA): Member, House Energy & Commerce Subcommittee on Health
Daneen Sekoni: VP, Policy & Advocacy, Cancer Support Community
Dana P. Goldman: Professor, Public Policy, Pharmacy & Economics, University of Southern California; Director, USC Schaeffer Institute for Public Policy & Government Service
Dr. Jennifer Ellis: Co-Chair, Health & Public Policy Committee, Association of Black Cardiologists & Cardiac Surgeon
Michael Ward: VP, Public Affairs & Government Relations, Alliance for Aging Research
LOCATION
Top of the Hill, 1 Constitution Ave NE, Washington, DC 20002, and streaming nationwide
DATE & TIME
Thursday, June 27
8:00 AM ET Registration & Networking
8:30 AM ET Programming begins
10:00 AM ET Programming concludes
Related: Medicare System Can Do More to Protect Beneficiaries
Tomorrow, Manatt Health will release a report sponsored by the Alliance, “Patient Impact of the Inflation Reduction Act: Administrative Options to Address Changed Incentives for Formulary and Utilization Management.” This compelling report investigates and reveals more that CMS can do under existing agency authority to protect beneficiaries, preserve access, and increase transparency. Stay tuned to the Alliance website.
|
5 Recommendations to Improve Public Understanding of Advisory Committees
This month during the U.S. Food & Drug Administration's (FDA) public meeting, “Optimizing FDA’s Use of and Processes for Advisory Committees,” Alliance President & CEO Sue Peschin outlined recommendations for the FDA’s consideration to improve public understanding of advisory committees and their role, our views on voting, training of advisory committee members, and thoughts on conflicts of interest.
|
Consistency is Key to Protecting
Older Adults Through Vaccination
On June 5, during the public comment portion of the Vaccines and Related Biological Products Advisory Committee (VRBPAC), the Alliance urged the FDA and Centers for Disease Control (CDC) to ensure timely access to updated COVID-19 vaccines, provide clear and simple recommendations for all ages, and address the need for better vaccine payment systems in long-term care.
As one of three co-conveners of the Champions for Vaccine Education, Equity and Progress, we are grateful for the FDA Advisory Committee's efforts to combat vaccine misinformation, and are confident in the coordinated steps taken between the FDA and CDC to protect older Americans during the 2024 respiratory virus season.
Related:
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
|
Podcast: Embracing Your Second Act
with Nell Irvin Painter
Starting over can be daunting, even terrifying, for many older adults. But for Nell Irvin Painter, an accomplished educator turned artist, it was as simple as placing a brush on a canvas.
In this episode of This Is Growing Old, we explore Nell’s fearless leap into the arts after a distinguished 30-year career as a professor and historian. Join us as we discuss her inspiring journey and the joy of embracing a new chapter in life.
|